A detailed history of Truvestments Capital LLC transactions in Axogen, Inc. stock. As of the latest transaction made, Truvestments Capital LLC holds 170 shares of AXGN stock, worth $1,278. This represents 0.0% of its overall portfolio holdings.

Number of Shares
170
Previous 170 -0.0%
Holding current value
$1,278
Previous $1,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 09, 2022

BUY
$6.99 - $10.0 $1,188 - $1,700
170 New
170 $1,000
Q1 2022

May 02, 2022

SELL
$7.26 - $10.7 $1,234 - $1,818
-170 Closed
0 $0
Q1 2021

May 18, 2021

BUY
$17.18 - $22.6 $2,920 - $3,842
170 New
170 $3,000

Others Institutions Holding AXGN

About Axogen, Inc.


  • Ticker AXGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 42,283,700
  • Market Cap $318M
  • Description
  • AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...
More about AXGN
Track This Portfolio

Track Truvestments Capital LLC Portfolio

Follow Truvestments Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Truvestments Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Truvestments Capital LLC with notifications on news.